cilostazol has been researched along with Diabetes Mellitus, Type 1 in 2 studies
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cilostazol has potential for protecting vessels against hyperglycemic injury and for accelerating the healing process after implantation of DES." | 1.39 | Cilostazol protects vessels against hyperglycemic injury and accelerates healing after implantation of drug-eluting stent in a type 1 diabetes mellitus rat aorta stent model. ( Ahn, Y; Cho, HH; Hong, MH; Jeong, HY; Jeong, MH; Kang, WS; Kee, HJ; Kim, YS; Kwon, JS, 2013) |
| "Cilostazol was reported to lower the production of superoxide significantly in situ." | 1.36 | Cilostazol ameliorates nephropathy in type 1 diabetic rats involving improvement in oxidative stress and regulation of TGF-Beta and NF-kappaB. ( Chen, CC; Chen, HC; Lee, HJ; Lee, WC; Lin, PY; Ou, TT; Wang, CY; Wang, J; Wen, MC, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kwon, JS | 1 |
| Kim, YS | 1 |
| Cho, HH | 1 |
| Kee, HJ | 1 |
| Hong, MH | 1 |
| Kang, WS | 1 |
| Jeong, HY | 1 |
| Jeong, MH | 1 |
| Ahn, Y | 1 |
| Lee, WC | 1 |
| Chen, HC | 1 |
| Wang, CY | 1 |
| Lin, PY | 1 |
| Ou, TT | 1 |
| Chen, CC | 1 |
| Wen, MC | 1 |
| Wang, J | 1 |
| Lee, HJ | 1 |
2 other studies available for cilostazol and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Cilostazol protects vessels against hyperglycemic injury and accelerates healing after implantation of drug-eluting stent in a type 1 diabetes mellitus rat aorta stent model.
Topics: Administration, Oral; Angioplasty, Balloon; Animals; Aorta; Aortic Diseases; Apoptosis; Blood Glucos | 2013 |
Cilostazol ameliorates nephropathy in type 1 diabetic rats involving improvement in oxidative stress and regulation of TGF-Beta and NF-kappaB.
Topics: Animals; Blood Glucose; Body Weight; Cilostazol; Creatinine; Diabetes Mellitus, Type 1; Diabetic Nep | 2010 |